<bill session="111" type="h" number="2400" updated="2023-01-11T13:19:14Z">
  <state datetime="2009-05-13">REFERRED</state>
  <status>
    <introduced datetime="2009-05-13"/>
  </status>
  <introduced datetime="2009-05-13"/>
  <titles>
    <title type="display">Strategies to Address Antimicrobial Resistance Act</title>
    <title type="official" as="introduced">To amend the Public Health Service Act to enhance efforts to address antimicrobial resistance.</title>
    <title type="short" as="introduced">Strategies to Address Antimicrobial Resistance Act</title>
  </titles>
  <sponsor bioguide_id="M001142"/>
  <cosponsors>
    <cosponsor bioguide_id="B001230" joined="2009-07-09"/>
    <cosponsor bioguide_id="C000380" joined="2010-04-26"/>
    <cosponsor bioguide_id="G000410" joined="2009-07-09"/>
    <cosponsor bioguide_id="M000404" joined="2010-07-21"/>
  </cosponsors>
  <actions>
    <action datetime="2009-05-13">
      <text>Introduced in House</text>
    </action>
    <action datetime="2009-05-13">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR E1142-1143"/>
    </action>
    <action datetime="2009-05-13" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2009-05-14">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Advisory bodies"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug therapy"/>
    <term name="Executive agency funding and structure"/>
    <term name="Government information and archives"/>
    <term name="Health information and medical records"/>
    <term name="Health programs administration and funding"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Medical research"/>
    <term name="Prescription drugs"/>
    <term name="Research administration and funding"/>
    <term name="Veterinary medicine and animal diseases"/>
  </subjects>
  <amendments/>
  <summary date="2009-09-16T21:26:23Z" status="Introduced in House">Strategies to Address Antimicrobial Resistance Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS) to establish the Antimicrobial Resistance Office. Requires the Secretary to establish the Public Health Antimicrobial Advisory Board to advise the Director of the Office (Director).

Requires the Director to update the Public Health Action Plan to Combat Antimicrobial Resistance within 18 months.

Requires the Secretary, acting through the Director, the Director of the Centers for Disease Control and Prevention (CDC), and the Director of the National Institutes of Health (NIH), to: (1) develop an antimicrobial resistance strategic research plan; and (2) establish at least ten Antimicrobial Resistance Surveillance and Research Network sites.

Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary to require each sponsor of an approved human antimicrobial drug product sold or distributed in the United States to submit antimicrobial drug sales and distribution data.

Requires that an application for a new animal drug contain information to ensure that reported data is comparable and reliable. Requires (currently, permits) the Secretary to share information reported in a new animal drug application with the Antimicrobial Resistance Task Force.

Sets forth provisions for the Secretary to secure reliable and comparable animal and human antimicrobial drug consumption data.

Requires the Under Secretary for Health of the Department of Veterans Affairs (VA), the Administrator of the Centers for Medicare &amp; Medicaid Services, and the Director to work together to identify and report upon interventions that prevent and control the development of antimicrobial resistance.</summary>
</bill>
